YL Biologics Ltd.

  • Corporate Profile
  • Message
  • Business Operations
  • News
  • Contact us
  • JP
  • EN

News

  • April 23, 2014 Joint Venture for Biosimilar Development Launched
    Shareholders: Yoshindo(Toyama, Japan) 55%, Lupin(Mumbai, India) 45% ”read more” link to press release PDF.
  • 陽進堂
  • LUPIN
  • エイワイファーマ株式会社

Copyright © 2018 YL Biologics All rights Reserved.